Buscar
OptimizeRx Corp
OPRXAñadir a la lista de seguimiento
6.050USD
-0.220-3.51%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
113.53MCap. mercado
16.38P/E TTM
Más Datos de OptimizeRx Corp Compañía
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
Información de OptimizeRx Corp
Símbolo de cotizaciónOPRX
Nombre de la empresaOptimizeRx Corp
Fecha de salida a bolsaMay 18, 2005
Director ejecutivoSilvestro (Stephen L)
Número de empleados106
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 18
Dirección260 Charles Street
CiudadWALTHAM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal02453
Teléfono12486516558
Sitio Webhttps://www.optimizerx.com/
Símbolo de cotizaciónOPRX
Fecha de salida a bolsaMay 18, 2005
Director ejecutivoSilvestro (Stephen L)
Ejecutivos de OptimizeRx Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
423.97K
+8.14%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.51K
-4.90%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
81.83K
+42.18%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
72.86K
-2.50%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
68.86K
+50.12%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
66.88K
-4.03%
Ms. Catherine M. Klema
Ms. Catherine M. Klema
Independent Director
Independent Director
46.27K
+74.60%
Mr. Andy D'Silva
Mr. Andy D'Silva
Chief Business Officer
Chief Business Officer
44.73K
-3.51%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
32.73K
-5.48%
Ms. Lynn O'Connor Vos
Ms. Lynn O'Connor Vos
Independent Chairperson of the Board
Independent Chairperson of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
423.97K
+8.14%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.51K
-4.90%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
81.83K
+42.18%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
72.86K
-2.50%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
68.86K
+50.12%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
66.88K
-4.03%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de OptimizeRx Corp?
Los cinco principales accionistas de OptimizeRx Corp son: Mr. James (Jim) Lang
¿Cuántas instituciones poseen acciones de OptimizeRx Corp (OPRX)?
A fecha de 2026Q1, 300 instituciones poseen acciones de OptimizeRx Corp, con un valor de mercado combinado de aproximadamente 15.47M, lo que representa el 82.46% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -5161941.00.